Rank | Gene Set | Z-score |
---|---|---|
1 | DNA deamination (GO:0045006) | 8.41935890 |
2 | cytidine metabolic process (GO:0046087) | 7.72561319 |
3 | cytidine catabolic process (GO:0006216) | 7.72561319 |
4 | cytidine deamination (GO:0009972) | 7.72561319 |
5 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 7.60861069 |
6 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 6.75516323 |
7 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.83284944 |
8 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 4.61987837 |
9 | sequestering of actin monomers (GO:0042989) | 4.36194759 |
10 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 4.30602738 |
11 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.25288334 |
12 | ATP synthesis coupled proton transport (GO:0015986) | 4.25288334 |
13 | actin nucleation (GO:0045010) | 4.16395818 |
14 | regulation of cellular amino acid metabolic process (GO:0006521) | 4.07565899 |
15 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 4.02131436 |
16 | proteasome assembly (GO:0043248) | 3.96526720 |
17 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.88657597 |
18 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.88657597 |
19 | respiratory electron transport chain (GO:0022904) | 3.87931891 |
20 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.86721729 |
21 | electron transport chain (GO:0022900) | 3.81784245 |
22 | protein neddylation (GO:0045116) | 3.78167997 |
23 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.76094981 |
24 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.76094981 |
25 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.76094981 |
26 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.75532143 |
27 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.74999990 |
28 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.74999990 |
29 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.72920311 |
30 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.61889286 |
31 | negative regulation of ligase activity (GO:0051352) | 3.56949952 |
32 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.56949952 |
33 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.54416256 |
34 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.54416256 |
35 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.53656399 |
36 | negative regulation of T cell apoptotic process (GO:0070233) | 3.51646508 |
37 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.49031466 |
38 | protein deneddylation (GO:0000338) | 3.46560568 |
39 | negative regulation by host of viral transcription (GO:0043922) | 3.46138522 |
40 | cullin deneddylation (GO:0010388) | 3.34847829 |
41 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 3.34684651 |
42 | regulation of regulatory T cell differentiation (GO:0045589) | 3.29081518 |
43 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.28890141 |
44 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.26125334 |
45 | platelet dense granule organization (GO:0060155) | 3.25039200 |
46 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 3.24662701 |
47 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.20295158 |
48 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.17039695 |
49 | termination of RNA polymerase III transcription (GO:0006386) | 3.17039695 |
50 | metallo-sulfur cluster assembly (GO:0031163) | 3.16049770 |
51 | iron-sulfur cluster assembly (GO:0016226) | 3.16049770 |
52 | pyrimidine nucleoside catabolic process (GO:0046135) | 3.12778018 |
53 | positive regulation of ligase activity (GO:0051351) | 3.07312575 |
54 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.04925538 |
55 | protein complex biogenesis (GO:0070271) | 3.04087873 |
56 | mannosylation (GO:0097502) | 2.98086097 |
57 | respiratory chain complex IV assembly (GO:0008535) | 2.97433495 |
58 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.94928358 |
59 | positive regulation of B cell differentiation (GO:0045579) | 2.90900722 |
60 | cellular response to interleukin-15 (GO:0071350) | 2.89727491 |
61 | eosinophil chemotaxis (GO:0048245) | 2.88498672 |
62 | rRNA modification (GO:0000154) | 2.87953489 |
63 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 2.87574232 |
64 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.87111277 |
65 | regulation of cellular amine metabolic process (GO:0033238) | 2.86567212 |
66 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.84965009 |
67 | positive regulation of cell cycle arrest (GO:0071158) | 2.84765246 |
68 | protein-cofactor linkage (GO:0018065) | 2.83633305 |
69 | negative regulation of lymphocyte apoptotic process (GO:0070229) | 2.77250239 |
70 | cytochrome complex assembly (GO:0017004) | 2.76798605 |
71 | negative regulation of viral genome replication (GO:0045071) | 2.76165608 |
72 | negative T cell selection (GO:0043383) | 2.75723158 |
73 | branched-chain amino acid catabolic process (GO:0009083) | 2.74912361 |
74 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 2.73139144 |
75 | positive regulation of interleukin-8 secretion (GO:2000484) | 2.72649446 |
76 | positive regulation of calcium-mediated signaling (GO:0050850) | 2.72252152 |
77 | positive thymic T cell selection (GO:0045059) | 2.72079954 |
78 | hydrogen ion transmembrane transport (GO:1902600) | 2.68975042 |
79 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.68960190 |
80 | cytolysis (GO:0019835) | 2.68627761 |
81 | chaperone-mediated protein transport (GO:0072321) | 2.67625862 |
82 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.64770735 |
83 | positive T cell selection (GO:0043368) | 2.64548617 |
84 | pyrimidine ribonucleoside metabolic process (GO:0046131) | 2.64377944 |
85 | ATP biosynthetic process (GO:0006754) | 2.62979927 |
86 | regulation of chronic inflammatory response (GO:0002676) | 2.62825088 |
87 | oxidative phosphorylation (GO:0006119) | 2.62742370 |
88 | eosinophil migration (GO:0072677) | 2.62348564 |
89 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.61438263 |
90 | NADH dehydrogenase complex assembly (GO:0010257) | 2.61438263 |
91 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.61438263 |
92 | regulation of isotype switching to IgG isotypes (GO:0048302) | 2.61339098 |
93 | DNA demethylation (GO:0080111) | 2.60331887 |
94 | regulation of ligase activity (GO:0051340) | 2.59615498 |
95 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.59565231 |
96 | T cell migration (GO:0072678) | 2.58250441 |
97 | GPI anchor biosynthetic process (GO:0006506) | 2.56878363 |
98 | proton transport (GO:0015992) | 2.56078825 |
99 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.55504163 |
100 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.55504163 |
Rank | Gene Set | Z-score |
---|---|---|
1 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 5.14192731 |
2 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 4.43207061 |
3 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 4.22818212 |
4 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.94458702 |
5 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.41850854 |
6 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.11534525 |
7 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.95164154 |
8 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.93378772 |
9 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.89943951 |
10 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.73712611 |
11 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.50127166 |
12 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.49403109 |
13 | VDR_22108803_ChIP-Seq_LS180_Human | 2.47350766 |
14 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.40661261 |
15 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.39885272 |
16 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.34339331 |
17 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.29814125 |
18 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.23927972 |
19 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.17970206 |
20 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.05720705 |
21 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.03982855 |
22 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.00675637 |
23 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.93930767 |
24 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.92515031 |
25 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.91833548 |
26 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.85178230 |
27 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.77149489 |
28 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.68455888 |
29 | MYB_26560356_Chip-Seq_TH2_Human | 1.62466455 |
30 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.61230104 |
31 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.59286412 |
32 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.54066382 |
33 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.52741767 |
34 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.51486268 |
35 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.50765447 |
36 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.46138983 |
37 | GATA3_26560356_Chip-Seq_TH2_Human | 1.40655411 |
38 | EWS_26573619_Chip-Seq_HEK293_Human | 1.39728817 |
39 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.38156486 |
40 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.37518542 |
41 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.36692697 |
42 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.36302582 |
43 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.36261853 |
44 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.34844889 |
45 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.29321533 |
46 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.29154385 |
47 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.29113132 |
48 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.28890448 |
49 | AR_20517297_ChIP-Seq_VCAP_Human | 1.28670248 |
50 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.28599654 |
51 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.28346489 |
52 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.26383638 |
53 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.26283612 |
54 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.22981766 |
55 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.22379051 |
56 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.21879059 |
57 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.21764279 |
58 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.20573828 |
59 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.18273330 |
60 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.17166402 |
61 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.16863605 |
62 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.16863605 |
63 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.16614027 |
64 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.16050273 |
65 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10275001 |
66 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.10271352 |
67 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.08665961 |
68 | ERG_20517297_ChIP-Seq_VCAP_Human | 1.06710759 |
69 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.06707193 |
70 | NCOR_22424771_ChIP-Seq_293T_Human | 1.06117991 |
71 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.06117326 |
72 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.05806106 |
73 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.04818572 |
74 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.04429443 |
75 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.04429443 |
76 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.04383010 |
77 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.04002608 |
78 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.03640836 |
79 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.02536895 |
80 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.02251210 |
81 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.02085208 |
82 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.02085208 |
83 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.01348864 |
84 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.00900540 |
85 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.00366465 |
86 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.00101553 |
87 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.00097003 |
88 | FUS_26573619_Chip-Seq_HEK293_Human | 1.00063572 |
89 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.00029498 |
90 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.99833593 |
91 | GATA3_26560356_Chip-Seq_TH1_Human | 0.98981317 |
92 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.98650593 |
93 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.97710281 |
94 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.97104243 |
95 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.96820641 |
96 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95937923 |
97 | TTF2_22483619_ChIP-Seq_HELA_Human | 0.95394206 |
98 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.94879049 |
99 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.94396891 |
100 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.92926025 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0005671_abnormal_response_to | 4.43649418 |
2 | MP0002102_abnormal_ear_morphology | 3.04239630 |
3 | MP0006072_abnormal_retinal_apoptosis | 2.59898642 |
4 | MP0008877_abnormal_DNA_methylation | 2.49188902 |
5 | MP0009785_altered_susceptibility_to | 2.41998834 |
6 | MP0004147_increased_porphyrin_level | 2.40058721 |
7 | MP0009333_abnormal_splenocyte_physiolog | 2.23939908 |
8 | MP0000372_irregular_coat_pigmentation | 2.14807415 |
9 | MP0008995_early_reproductive_senescence | 2.12648475 |
10 | MP0001835_abnormal_antigen_presentation | 2.03147888 |
11 | MP0005645_abnormal_hypothalamus_physiol | 2.00329314 |
12 | MP0008058_abnormal_DNA_repair | 1.97923212 |
13 | MP0005646_abnormal_pituitary_gland | 1.95626466 |
14 | MP0003763_abnormal_thymus_physiology | 1.95134118 |
15 | MP0003786_premature_aging | 1.87893065 |
16 | MP0009697_abnormal_copulation | 1.81140194 |
17 | MP0005000_abnormal_immune_tolerance | 1.77081048 |
18 | MP0005253_abnormal_eye_physiology | 1.74340210 |
19 | MP0001984_abnormal_olfaction | 1.71905995 |
20 | MP0002837_dystrophic_cardiac_calcinosis | 1.69784550 |
21 | MP0008789_abnormal_olfactory_epithelium | 1.68767930 |
22 | MP0006292_abnormal_olfactory_placode | 1.68663052 |
23 | MP0003195_calcinosis | 1.65981653 |
24 | MP0001800_abnormal_humoral_immune | 1.65090627 |
25 | MP0003880_abnormal_central_pattern | 1.63864546 |
26 | MP0002166_altered_tumor_susceptibility | 1.59048031 |
27 | MP0002148_abnormal_hypersensitivity_rea | 1.58879851 |
28 | MP0006082_CNS_inflammation | 1.55303193 |
29 | MP0003787_abnormal_imprinting | 1.53939658 |
30 | MP0002420_abnormal_adaptive_immunity | 1.51983557 |
31 | MP0008872_abnormal_physiological_respon | 1.51394969 |
32 | MP0002723_abnormal_immune_serum | 1.51298515 |
33 | MP0001764_abnormal_homeostasis | 1.47237005 |
34 | MP0003011_delayed_dark_adaptation | 1.47175110 |
35 | MP0005379_endocrine/exocrine_gland_phen | 1.45650229 |
36 | MP0001819_abnormal_immune_cell | 1.45485423 |
37 | MP0005551_abnormal_eye_electrophysiolog | 1.44958821 |
38 | MP0001790_abnormal_immune_system | 1.41620957 |
39 | MP0005387_immune_system_phenotype | 1.41620957 |
40 | MP0002277_abnormal_respiratory_mucosa | 1.40844086 |
41 | MP0001905_abnormal_dopamine_level | 1.40516777 |
42 | MP0006035_abnormal_mitochondrial_morpho | 1.38114405 |
43 | MP0002163_abnormal_gland_morphology | 1.37615685 |
44 | MP0001529_abnormal_vocalization | 1.36722863 |
45 | MP0006036_abnormal_mitochondrial_physio | 1.34671188 |
46 | MP0005025_abnormal_response_to | 1.32464373 |
47 | MP0001873_stomach_inflammation | 1.30718788 |
48 | MP0004145_abnormal_muscle_electrophysio | 1.30678538 |
49 | MP0005360_urolithiasis | 1.28487534 |
50 | MP0002006_tumorigenesis | 1.27585006 |
51 | MP0000689_abnormal_spleen_morphology | 1.24327630 |
52 | MP0002398_abnormal_bone_marrow | 1.23705217 |
53 | MP0006276_abnormal_autonomic_nervous | 1.22313934 |
54 | MP0001968_abnormal_touch/_nociception | 1.21547078 |
55 | MP0002138_abnormal_hepatobiliary_system | 1.21480922 |
56 | MP0001919_abnormal_reproductive_system | 1.19593185 |
57 | MP0002452_abnormal_antigen_presenting | 1.18069767 |
58 | MP0000716_abnormal_immune_system | 1.18021718 |
59 | MP0002736_abnormal_nociception_after | 1.17836575 |
60 | MP0005410_abnormal_fertilization | 1.17688419 |
61 | MP0003866_abnormal_defecation | 1.17507867 |
62 | MP0001661_extended_life_span | 1.16860205 |
63 | MP0008875_abnormal_xenobiotic_pharmacok | 1.16464261 |
64 | MP0000703_abnormal_thymus_morphology | 1.15275364 |
65 | MP0005084_abnormal_gallbladder_morpholo | 1.14380404 |
66 | MP0004142_abnormal_muscle_tone | 1.13730061 |
67 | MP0002405_respiratory_system_inflammati | 1.12012019 |
68 | MP0002722_abnormal_immune_system | 1.10447279 |
69 | MP0005389_reproductive_system_phenotype | 1.10159004 |
70 | MP0005636_abnormal_mineral_homeostasis | 1.04817349 |
71 | MP0005075_abnormal_melanosome_morpholog | 0.99907343 |
72 | MP0001845_abnormal_inflammatory_respons | 0.99555617 |
73 | MP0000685_abnormal_immune_system | 0.99342291 |
74 | MP0005377_hearing/vestibular/ear_phenot | 0.97274954 |
75 | MP0003878_abnormal_ear_physiology | 0.97274954 |
76 | MP0010094_abnormal_chromosome_stability | 0.96019121 |
77 | MP0003137_abnormal_impulse_conducting | 0.94487437 |
78 | MP0002095_abnormal_skin_pigmentation | 0.93734885 |
79 | MP0005499_abnormal_olfactory_system | 0.93593419 |
80 | MP0005394_taste/olfaction_phenotype | 0.93593419 |
81 | MP0002429_abnormal_blood_cell | 0.92330093 |
82 | MP0005332_abnormal_amino_acid | 0.92224411 |
83 | MP0002693_abnormal_pancreas_physiology | 0.91151698 |
84 | MP0002876_abnormal_thyroid_physiology | 0.90234255 |
85 | MP0010155_abnormal_intestine_physiology | 0.89845098 |
86 | MP0003045_fibrosis | 0.89640343 |
87 | MP0004957_abnormal_blastocyst_morpholog | 0.87208887 |
88 | MP0003186_abnormal_redox_activity | 0.87087763 |
89 | MP0002234_abnormal_pharynx_morphology | 0.85367522 |
90 | MP0005083_abnormal_biliary_tract | 0.85334591 |
91 | MP0002638_abnormal_pupillary_reflex | 0.84345338 |
92 | MP0001853_heart_inflammation | 0.84262075 |
93 | MP0001485_abnormal_pinna_reflex | 0.83308039 |
94 | MP0003806_abnormal_nucleotide_metabolis | 0.80678569 |
95 | MP0009745_abnormal_behavioral_response | 0.79309175 |
96 | MP0001929_abnormal_gametogenesis | 0.77586253 |
97 | MP0008469_abnormal_protein_level | 0.76955790 |
98 | MP0009764_decreased_sensitivity_to | 0.76034667 |
99 | MP0009046_muscle_twitch | 0.75740372 |
100 | MP0001119_abnormal_female_reproductive | 0.75717148 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Aplastic anemia (HP:0001915) | 4.63193746 |
2 | Mitochondrial inheritance (HP:0001427) | 4.23294991 |
3 | Acute necrotizing encephalopathy (HP:0006965) | 4.23089187 |
4 | Severe combined immunodeficiency (HP:0004430) | 3.98919021 |
5 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.82034190 |
6 | Hepatocellular necrosis (HP:0001404) | 3.81671715 |
7 | 3-Methylglutaconic aciduria (HP:0003535) | 3.78223800 |
8 | Increased CSF lactate (HP:0002490) | 3.73465930 |
9 | Progressive macrocephaly (HP:0004481) | 3.67053059 |
10 | IgG deficiency (HP:0004315) | 3.62370787 |
11 | Acute encephalopathy (HP:0006846) | 3.58562443 |
12 | T lymphocytopenia (HP:0005403) | 3.55464204 |
13 | Hepatic necrosis (HP:0002605) | 3.44308295 |
14 | Abnormality of T cell number (HP:0011839) | 3.36248559 |
15 | Increased hepatocellular lipid droplets (HP:0006565) | 3.31917067 |
16 | Cerebral edema (HP:0002181) | 3.26354042 |
17 | Combined immunodeficiency (HP:0005387) | 3.16334011 |
18 | Thyroiditis (HP:0100646) | 3.11249732 |
19 | Pancreatic cysts (HP:0001737) | 3.06592887 |
20 | Lipid accumulation in hepatocytes (HP:0006561) | 3.00485496 |
21 | Hypoproteinemia (HP:0003075) | 2.90343665 |
22 | Autoimmune hemolytic anemia (HP:0001890) | 2.78050020 |
23 | True hermaphroditism (HP:0010459) | 2.77657071 |
24 | Increased IgM level (HP:0003496) | 2.77159678 |
25 | Increased intramyocellular lipid droplets (HP:0012240) | 2.76165179 |
26 | Abnormality of T cells (HP:0002843) | 2.73342294 |
27 | Type I transferrin isoform profile (HP:0003642) | 2.71393811 |
28 | Increased serum lactate (HP:0002151) | 2.69424188 |
29 | Abnormality of midbrain morphology (HP:0002418) | 2.68710257 |
30 | Molar tooth sign on MRI (HP:0002419) | 2.68710257 |
31 | Attenuation of retinal blood vessels (HP:0007843) | 2.67773133 |
32 | Lactic acidosis (HP:0003128) | 2.65985588 |
33 | Pancreatic fibrosis (HP:0100732) | 2.63605279 |
34 | Abnormality of eosinophils (HP:0001879) | 2.61919391 |
35 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.53501527 |
36 | Renal Fanconi syndrome (HP:0001994) | 2.51917377 |
37 | Chronic diarrhea (HP:0002028) | 2.49357494 |
38 | Pancytopenia (HP:0001876) | 2.46220388 |
39 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.43756031 |
40 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.43756031 |
41 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.41486662 |
42 | Optic disc pallor (HP:0000543) | 2.40303353 |
43 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.39980789 |
44 | Abolished electroretinogram (ERG) (HP:0000550) | 2.38375872 |
45 | Respiratory failure (HP:0002878) | 2.34274183 |
46 | Lethargy (HP:0001254) | 2.34132790 |
47 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.32405007 |
48 | Abnormality of alanine metabolism (HP:0010916) | 2.32405007 |
49 | Hyperalaninemia (HP:0003348) | 2.32405007 |
50 | Abnormal glycosylation (HP:0012345) | 2.28143319 |
51 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.28143319 |
52 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.28143319 |
53 | Abnormal protein glycosylation (HP:0012346) | 2.28143319 |
54 | Methylmalonic acidemia (HP:0002912) | 2.26494746 |
55 | Increased muscle lipid content (HP:0009058) | 2.26393913 |
56 | Methylmalonic aciduria (HP:0012120) | 2.21392717 |
57 | Decreased central vision (HP:0007663) | 2.20790654 |
58 | Congenital stationary night blindness (HP:0007642) | 2.19662606 |
59 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.15000082 |
60 | Renal cortical cysts (HP:0000803) | 2.13212247 |
61 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.11309918 |
62 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.11168662 |
63 | Constricted visual fields (HP:0001133) | 2.10667524 |
64 | B lymphocytopenia (HP:0010976) | 2.09985342 |
65 | Exertional dyspnea (HP:0002875) | 2.09266487 |
66 | Dicarboxylic aciduria (HP:0003215) | 2.09147342 |
67 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.09147342 |
68 | Exercise intolerance (HP:0003546) | 2.07223949 |
69 | Eosinophilia (HP:0001880) | 2.07169633 |
70 | Aplasia/hypoplasia of the uterus (HP:0008684) | 2.07009158 |
71 | Abnormality of B cell number (HP:0010975) | 2.06389319 |
72 | Abnormality of the prostate (HP:0008775) | 2.06090021 |
73 | Medial flaring of the eyebrow (HP:0010747) | 2.04026656 |
74 | Ketoacidosis (HP:0001993) | 2.03957318 |
75 | Nephronophthisis (HP:0000090) | 2.02186607 |
76 | Ketosis (HP:0001946) | 2.01943048 |
77 | CNS demyelination (HP:0007305) | 1.98365619 |
78 | Hypothermia (HP:0002045) | 1.95724787 |
79 | Nephrogenic diabetes insipidus (HP:0009806) | 1.88262605 |
80 | Hypomagnesemia (HP:0002917) | 1.88103046 |
81 | Pendular nystagmus (HP:0012043) | 1.86494600 |
82 | Hyperglycinemia (HP:0002154) | 1.85979428 |
83 | Generalized aminoaciduria (HP:0002909) | 1.84539929 |
84 | Granulocytopenia (HP:0001913) | 1.82837483 |
85 | Type 2 muscle fiber atrophy (HP:0003554) | 1.82467647 |
86 | Abnormality of the renal cortex (HP:0011035) | 1.80417770 |
87 | Hypoalbuminemia (HP:0003073) | 1.80314486 |
88 | Abnormal albumin level (HP:0012116) | 1.80314486 |
89 | Recurrent cutaneous fungal infections (HP:0011370) | 1.78537352 |
90 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.78537352 |
91 | Emotional lability (HP:0000712) | 1.78530296 |
92 | Type II lissencephaly (HP:0007260) | 1.76938569 |
93 | Abnormality of T cell physiology (HP:0011840) | 1.75835283 |
94 | Chronic sinusitis (HP:0011109) | 1.75337347 |
95 | Encephalitis (HP:0002383) | 1.74642382 |
96 | Congenital primary aphakia (HP:0007707) | 1.72225235 |
97 | Leukocytosis (HP:0001974) | 1.71106818 |
98 | Leukodystrophy (HP:0002415) | 1.70454945 |
99 | Abnormality of serum amino acid levels (HP:0003112) | 1.70062849 |
100 | Cerebral hypomyelination (HP:0006808) | 1.69041788 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TXK | 4.78649812 |
2 | KDR | 4.44562650 |
3 | TESK2 | 3.94462516 |
4 | BCKDK | 3.55129030 |
5 | ZAK | 3.11333483 |
6 | VRK2 | 2.68656991 |
7 | MAP4K2 | 2.58402680 |
8 | BUB1 | 2.33334563 |
9 | TRIM28 | 2.30875717 |
10 | MST4 | 2.23026490 |
11 | VRK1 | 2.17338126 |
12 | FRK | 2.11243020 |
13 | ADRBK2 | 2.00827400 |
14 | TLK1 | 1.88391860 |
15 | BCR | 1.80332648 |
16 | EIF2AK3 | 1.73395329 |
17 | ITK | 1.69883432 |
18 | NUAK1 | 1.65052811 |
19 | SRPK1 | 1.52577327 |
20 | LIMK1 | 1.49523340 |
21 | TESK1 | 1.49411836 |
22 | MAP4K1 | 1.49207509 |
23 | MAP2K7 | 1.43155310 |
24 | GRK1 | 1.40961074 |
25 | CSNK1G3 | 1.23369016 |
26 | RPS6KA4 | 1.23014099 |
27 | INSRR | 1.16786810 |
28 | WNK3 | 1.10306197 |
29 | CSNK1G1 | 1.10032911 |
30 | PINK1 | 1.04804871 |
31 | MAP3K4 | 1.04384669 |
32 | SCYL2 | 1.02599477 |
33 | TAOK3 | 1.01894788 |
34 | SYK | 0.97225077 |
35 | PRKCQ | 0.95926652 |
36 | GRK6 | 0.93942723 |
37 | FES | 0.93360214 |
38 | TEC | 0.91394805 |
39 | CSNK1A1L | 0.91084840 |
40 | PLK2 | 0.90956024 |
41 | PLK3 | 0.90365915 |
42 | CSNK1G2 | 0.88306437 |
43 | PLK4 | 0.85811173 |
44 | TNK2 | 0.83793645 |
45 | MAPK13 | 0.82893280 |
46 | WNK4 | 0.81347084 |
47 | DAPK1 | 0.79572395 |
48 | MUSK | 0.78873583 |
49 | ERBB3 | 0.78506966 |
50 | LCK | 0.77173807 |
51 | RPS6KA5 | 0.74564710 |
52 | NME1 | 0.74504786 |
53 | LYN | 0.73574978 |
54 | MAP3K12 | 0.65753911 |
55 | MATK | 0.64256402 |
56 | DYRK2 | 0.63161621 |
57 | IKBKB | 0.60107303 |
58 | ATR | 0.57676079 |
59 | EIF2AK1 | 0.55833330 |
60 | TIE1 | 0.55226362 |
61 | PLK1 | 0.54018157 |
62 | GRK7 | 0.53065570 |
63 | MAPKAPK3 | 0.52565726 |
64 | CCNB1 | 0.52455018 |
65 | PIK3CG | 0.51320107 |
66 | BMPR2 | 0.51112705 |
67 | BTK | 0.49608813 |
68 | CSNK1A1 | 0.48854560 |
69 | PHKG1 | 0.48572860 |
70 | PHKG2 | 0.48572860 |
71 | CSNK2A1 | 0.46295877 |
72 | CAMKK2 | 0.45982158 |
73 | PIM1 | 0.45438848 |
74 | PDK2 | 0.44366589 |
75 | MAP3K5 | 0.44153995 |
76 | NLK | 0.43358786 |
77 | PRKCE | 0.43248700 |
78 | CSK | 0.41236163 |
79 | EPHA3 | 0.40510319 |
80 | CSNK2A2 | 0.39120662 |
81 | AURKA | 0.37379429 |
82 | IKBKE | 0.37372322 |
83 | PRKCA | 0.36188368 |
84 | PIM2 | 0.35790986 |
85 | BMPR1B | 0.35703299 |
86 | TSSK6 | 0.35143797 |
87 | PRKACA | 0.35038736 |
88 | OBSCN | 0.34400875 |
89 | OXSR1 | 0.34349285 |
90 | CDC7 | 0.33642243 |
91 | MAPKAPK5 | 0.33024793 |
92 | EPHA4 | 0.32366361 |
93 | ZAP70 | 0.31962754 |
94 | AURKB | 0.31559303 |
95 | PAK1 | 0.30939990 |
96 | JAK3 | 0.30770584 |
97 | IGF1R | 0.30710825 |
98 | DAPK2 | 0.30595944 |
99 | MYLK | 0.29785843 |
100 | ROCK1 | 0.28487771 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Proteasome_Homo sapiens_hsa03050 | 5.27085613 |
2 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.74015878 |
3 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.71472707 |
4 | Parkinsons disease_Homo sapiens_hsa05012 | 3.17226106 |
5 | Protein export_Homo sapiens_hsa03060 | 2.84340559 |
6 | RNA polymerase_Homo sapiens_hsa03020 | 2.83619722 |
7 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.23084042 |
8 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.14519793 |
9 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.04900017 |
10 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.97009662 |
11 | Alzheimers disease_Homo sapiens_hsa05010 | 1.96624476 |
12 | Huntingtons disease_Homo sapiens_hsa05016 | 1.95508946 |
13 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.95282381 |
14 | Allograft rejection_Homo sapiens_hsa05330 | 1.94467434 |
15 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.94039366 |
16 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.87696455 |
17 | Homologous recombination_Homo sapiens_hsa03440 | 1.79248351 |
18 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.77305054 |
19 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.67099984 |
20 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.63582772 |
21 | Mismatch repair_Homo sapiens_hsa03430 | 1.58193655 |
22 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.57481874 |
23 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.39233363 |
24 | Spliceosome_Homo sapiens_hsa03040 | 1.35670095 |
25 | Ribosome_Homo sapiens_hsa03010 | 1.34255874 |
26 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.33616598 |
27 | DNA replication_Homo sapiens_hsa03030 | 1.33260467 |
28 | RNA degradation_Homo sapiens_hsa03018 | 1.32669079 |
29 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.30415347 |
30 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.27368186 |
31 | Phototransduction_Homo sapiens_hsa04744 | 1.21375430 |
32 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.15925593 |
33 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.14170475 |
34 | Peroxisome_Homo sapiens_hsa04146 | 1.12884309 |
35 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.10467352 |
36 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.09128437 |
37 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.08932773 |
38 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.08867820 |
39 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.08422180 |
40 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.07671473 |
41 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.02967179 |
42 | RNA transport_Homo sapiens_hsa03013 | 1.00962412 |
43 | Purine metabolism_Homo sapiens_hsa00230 | 0.99895217 |
44 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.99098978 |
45 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.97587200 |
46 | Asthma_Homo sapiens_hsa05310 | 0.97368089 |
47 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.94893144 |
48 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.94520118 |
49 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.87987689 |
50 | Basal transcription factors_Homo sapiens_hsa03022 | 0.85694132 |
51 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.85068365 |
52 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.84656630 |
53 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.84339694 |
54 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.78135284 |
55 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.77960069 |
56 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.77506513 |
57 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.76482694 |
58 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.74128495 |
59 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.72038625 |
60 | Base excision repair_Homo sapiens_hsa03410 | 0.71589952 |
61 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.71128910 |
62 | Olfactory transduction_Homo sapiens_hsa04740 | 0.66742335 |
63 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.65661209 |
64 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.64120294 |
65 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.63378209 |
66 | Metabolic pathways_Homo sapiens_hsa01100 | 0.62413061 |
67 | Retinol metabolism_Homo sapiens_hsa00830 | 0.60365207 |
68 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.55498854 |
69 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.53985864 |
70 | Measles_Homo sapiens_hsa05162 | 0.53674380 |
71 | Taste transduction_Homo sapiens_hsa04742 | 0.53012544 |
72 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.52009310 |
73 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.51647087 |
74 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.50874920 |
75 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.50379444 |
76 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.49457831 |
77 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.49059618 |
78 | Viral myocarditis_Homo sapiens_hsa05416 | 0.48781251 |
79 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.46811537 |
80 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.46610459 |
81 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.46062448 |
82 | Shigellosis_Homo sapiens_hsa05131 | 0.45456304 |
83 | Salmonella infection_Homo sapiens_hsa05132 | 0.42475363 |
84 | Nicotine addiction_Homo sapiens_hsa05033 | 0.42175546 |
85 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.41460649 |
86 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.39618490 |
87 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.38843406 |
88 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.38369599 |
89 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.36688904 |
90 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.35105340 |
91 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.32829675 |
92 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.30736314 |
93 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.29021290 |
94 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.26729683 |
95 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.26142587 |
96 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.24047773 |
97 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.23980889 |
98 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.23659140 |
99 | Carbon metabolism_Homo sapiens_hsa01200 | 0.23065041 |
100 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.22838925 |